Viewing Study NCT01954992


Ignite Creation Date: 2025-12-24 @ 3:42 PM
Ignite Modification Date: 2026-02-17 @ 4:13 PM
Study NCT ID: NCT01954992
Status: RECRUITING
Last Update Posted: 2024-12-31
First Post: 2013-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Sponsor: Eleison Pharmaceuticals LLC.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None glufosfamide View
None 5-FU View
None metastatic pancreatic adenocarcinoma View